By David Wild
A new three-balloon system for treating obesity does not require endoscopic placement and can produce at least a 5% loss of total body weight in nearly two-thirds of patients who receive it, researchers have found.
The balloons (Obalon, Obalon Therapeutics), which are swallowed as capsules in three stages and inflated with nitrogen gas, also significantly improved systolic blood pressure, fasting glucose, low-density lipoprotein cholesterol and triglycerides, while a control sham